# 7-week Study With CT-155 in People With Schizophrenia

> **NCT05486312** · NA · COMPLETED · sponsor: **Click Therapeutics, Inc.** · enrollment: 72 (actual)

## Conditions studied

- Schizophrenia

## Interventions

- **DEVICE:** CT-155 smartphone app

## Key facts

- **NCT ID:** NCT05486312
- **Lead sponsor:** Click Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-07-05
- **Primary completion:** 2022-09-22
- **Final completion:** 2022-12-12
- **Target enrollment:** 72 (ACTUAL)
- **Last updated:** 2025-05-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05486312

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05486312, "7-week Study With CT-155 in People With Schizophrenia". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05486312. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*